Securities and Exchange Board of India (SEBI) signed off on 13 initial public offerings (IPOs), including Urban Company and BoAt’s parent Imagine Marketing, facilitating fresh fundraises of nearly ₹15,000 crore in the next few months.

SEBI IPO Approvals Drive Market Momentum

SEBI (Securities and Exchange Board of India), situated in Mumbai, is the market regulator that controls the securities and capital market of India. The main functions of the Company are to safeguard investor rights, manage the securities market, and promote the raising of funds through the issue of shares.

In performing its duties, SEBI is reported to have given a nod to 13 IPOs. The primary market is thus drawn into action, and there is a prospect of ₹15,000 crore of capital coming in.

Key Highlights of Approved IPOs

The list of IPOs just approved includes the names of prominent consumer-focused companies such as Urban Company, a rapidly growing Indian home services marketplace, and Imagine Marketing, the parent company of BoAt, the Indian leader in wearables and audio products.

Urban Company is aiming to gather about ₹1,900 crores through the issuance of a mix of new equity shares as well as an offer for sale. The company, which is backed by top investors, is completing its IPO preparations for the last week of this month.

Also Read: Urban Company IPO Price Band Fixed at ₹98-103

On the other hand, Imagine Marketing who went in for a confidential filing of the draft papers in April 2025 has officially got the approval for the second IPO after the company decided to ditch its 2022 plan. It is predicted that the public issue will be welcomed by a strong retail and institutional investor audience given the company’s position in the smart wearables and consumer electronics field.

The others that have found their name on the list SEBI clearance for are:

• Juniper Green Energy

• Jain Resource Recycling

• Ravi Infrabuild Projects

• Mouri Tech

• Allchem Lifescience

• Omnitech Engineering

• KSH International

• Pace Digitek

• Priority Jewels

• Corona Remedies

• Om Freight Forwarders

This is just about one of the most weeks with numerous IPO approvals in recent times.

Also Read: Upcoming IPOs in September: Market Set for Action

Growing Pipeline of IPO Approvals

Most of these companies submitted their draft red herring prospectuses (DRHPs) between March and June, showing the walk of India’s equity markets.

The jump in the number of given approvals happens when the primary market is very lively, and investors are very keen to participate. To exemplify, in August 2025 alone:

• 12 companies started trading on main exchanges.

• 34 SMEs were listed on SME platforms.

In July, 13 more companies went public on the main board.

As per the data from SEBI, there are over 70 companies such as Lenskart, Hero Motors, Indira IVF, and Canara Robeco Asset Management waiting for the nod to IPO. The combined potential of these firms to gather close to ₹1.4 trillion on approval is anticipated.

Implications for India’s Capital Market

The flood of IPO approvals sends the message that SEBI is striving for faster actions and is concentrated on not letting any queues of IPO resolutions. This step is sanctioned to raise money supply, diversify investors’ choices, and give firms the opportunity to expand their business.

The coming of such big names as the sister company of Urban Company and BoAt’s parent Imagine Marketing is bound to create a highly attractive basket of consumer, technology, and lifestyle stocks for investors.

IPO Market Outlook 2025

Projections from the industry point to a bright future for the Indian IPO market, reflected in:

• Growing participation of retail investors in the equity markets.

• Rising inflows of foreign institutional investments (FIIs).

• Range of sectors from renewables to technology.

• The demand for consumer and lifestyle brands such as BoAt is very strong and this trend will continue.

This will mark the primary market as a significant instrument for drawing capital for the remainder of FY25, with an unlocked fundraising potential of almost ₹15,000 crore through these 13 approvals.

Impact of Market and SEBI IPO Approvals

The SEBI IPO decisions from the regulator show that it trusts India’s capital markets very much. The regulator’s green light for companies such as Urban Company and BoAt’s parent carves out a large investor base and guarantees the continuity of capital raising in the next quarters.

The waiting list is never going to be empty, and there are more than 70 companies in the pipeline for IPOs, meaning that the SEBI IPO approvals will still be the main factor to drive the stock market in India, and this will make 2025 one of the years with the most capital raising activities in the country.

FAQ’s

READ MORE ON

Read the full article here: SEBI Approves IPO Proposals of 13 Companies — For more updates, visit Wittiya – Top Business News, Stock Market Insights & Financial Updates (Wittiya).

Corona Remedies, a pharmaceutical company headquartered in Ahmedabad, has filed draft papers with the Securities and Exchange Board of India (SEBI) for an ₹800 crore IPO. The offering will be an offer for sale (OFS), where promoters and existing investors will sell their stakes. The IPO is being managed by JM Financial, IIFL Capital Services, and Kotak Mahindra Capital Company.

Corona Remedies, a prominent pharmaceutical company based in Ahmedabad, has filed draft documents with the Securities and Exchange Board of India (SEBI) for its proposed initial public offering (IPO) worth ₹800 crore. The company aims to list its shares on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) through this offering, which will be entirely an offer for sale (OFS). This means no new shares will be issued, and instead, the promoters and existing investors will sell their stakes.

As outlined in the draft red herring prospectus (DRHP), the IPO will allow the promoter group, led by Dr. Kirtikumar Laxmidas Mehta, and the current investor ChrysCapital, along with its affiliates Sepia Investments, Anchor Partners, and Sage Investment Trust, to offload their shares. ChrysCapital currently holds a 27.5% stake in the company.

The lead book-running managers for the IPO are JM Financial, IIFL Capital Services, and Kotak Mahindra Capital Company.

About Corona Remedies

Founded and headquartered in Ahmedabad, Gujarat, Corona Remedies is a leading player in the Indian pharmaceutical market. The company specializes in the development, manufacturing, and marketing of pharmaceutical products across various therapeutic segments. These include women’s health, cardiovascular and diabetes care, pain management, and urology, among others.

Corona Remedies has established itself as one of the fastest-growing companies in the Indian Pharmaceutical Market (IPM), ranking as the second fastest-growing firm among the top 30 based on domestic sales from MAT December 2021 to MAT December 2024, according to a CRISIL report. As of December 31, 2024, the company’s product portfolio includes 67 brands, and its revenue for FY24 stood at ₹1,014.5 crore.

Promoter Group

The promoters of the company include Dr. Kirtikumar Laxmidas Mehta, Niravkumar Kirtikumar Mehta, and Ankur Kirtikumar Mehta, who have been instrumental in steering the company to its current success. The company’s strategic focus on diversified therapeutic areas has contributed to its strong position in the competitive pharmaceutical sector.

This IPO marks a significant step for the company as it seeks to expand its reach and continue growing in the Indian and global pharmaceutical markets. The funds raised will be used by the selling shareholders, who are looking to capitalize on the growth of the company.

Read the full article here: Corona Remedies Sets Sails for a Grand ₹800 Crore IPO — For more updates, visit Wittiya – Top Business News, Stock Market Insights & Financial Updates (Wittiya).